Month: June 2022

Immunovant plans to initiate two placebo-controlled Phase 3 clinical trials of batoclimab in thyroid eye disease (TED) in the second half of calendar year 2022 with top-line data expected for both in the first half of calendar year 2025 Immunovant estimates annual addressable U.S. TED population for a new mechanism of action to be 8,000-18,000 patients Immunovant on track to initiate pivotal Phase 3 clinical trial of batoclimab in myasthenia gravis (MG), by the end of June 2022 Cash balance of $494 million as of March 31, 2022 expected to provide cash runway into calendar year 2025NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today announced that it has achieved alignment with the United...

Net Sales Growth of 56.0%Comparable Sales Growth of 42.2%Net Income Decreases to $1.9 million from $2.1 million in the Prior Year Period Adjusted EBITDA1 Increases to $6.4 million from $5.3 million in the Prior Year Period STAMFORD, Conn., June 08, 2022 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the home furnishing brand best known for its Sactionals, The World’s Most Adaptable Couch™, today announced financial results for the first quarter of fiscal 2023, which ended May 1, 2022. Shawn Nelson, Chief Executive Officer, stated, “Lovesac’s strong performance in the first quarter exceeded expectations at the top and bottom lines and, perhaps more importantly, defied the macro headwinds that are negatively impacting consumers and the broader economy. These first quarter results build on...

Continued RV Demand and Operating Excellence Drive Strong ResultsNet sales for the third quarter were $4.66 billion, an increase of 34.6% as compared to the third quarter of fiscal 2021. Consolidated gross profit margin for the third quarter was 17.3%, a 270 basis point improvement over the comparable prior-year period. Earnings per share for the third quarter were $6.32 per diluted share, an increase of 92.1% as compared to $3.29 per diluted share in the same period of the prior fiscal year. Consolidated RV backlog as of April 30, 2022 was $13.88 billion. During the third quarter, the Company repurchased approximately $40.0 million of common stock under its $250.0 million share repurchase program. During the third quarter, the Company made principal payments of approximately $124.6 million on its Term Loan. Subsequent to the end of...

Net sales increased 17.7% for the quarter and 10.4% for the full year Gross profit increased 10.1% for the quarter Balance sheet remains strongGONZALES, La., June 08, 2022 (GLOBE NEWSWIRE) — Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) today reported results for the fourth quarter and fiscal year 2022, which ended April 3, 2022. “Our performance in the fourth quarter and full year of fiscal 2022 was a continuation of the growth we have experienced over the past two years,” said Olivia Elliott, President and Chief Executive Officer. “As we begin fiscal 2023, our Company remains financially strong, and we are excited about our opportunities for continued profitable growth in the future.” Financial Results Net income for the fourth quarter of fiscal 2022 was $2,435,000, or $0.24 per diluted share, on net sales of $25.7...

BEIJING, June 08, 2022 (GLOBE NEWSWIRE) — Kingsoft Cloud Holdings Limited (“Kingsoft Cloud” or the “Company”) (NASDAQ: KC), a leading independent cloud service provider in China, today announced its unaudited financial results for the first quarter ended March 31, 2022. Mr. Yulin Wang, Chief Executive Officer of Kingsoft Cloud, commented, “Despite the rising uncertainty in the macro-environment and recent pandemic resurgence in China, we adhered to our strategy of pursuing steady and high-quality growth while improving our business stability and profitability. We are pleased to deliver another quarter of solid performance, with revenue up 20% year-over-year and adjusted gross profit increased by 152% quarter-over-quarter to RMB83.6 million. These results further testify to the resilience of our business, our execution capabilities,...

— First Quarter Total Loan Origination Volume Grew 95.4% to RMB8,153 Million —— First Quarter Net Income Grew 54.3% to RMB144.6 Million — SHANGHAI, China, June 08, 2022 (GLOBE NEWSWIRE) — Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced its unaudited financial results for the first quarter ended March 31, 2022. First Quarter 2022 Operational and Financial Highlights:Loan origination volume1 was RMB8,153 million (US$1,286 million), representing an increase of 95.4% from the same period of 2021.Average borrowing amount per borrowing was RMB8,736 (US$1,378), representing an increase of 41.0% from the same period of 2021.Repeat borrowing rate2 was 70.1%, compared with repeat borrowing rate of 74.2% in the same period of 2021.Net revenue...